a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) —Biomarker developer Pronota has raised an additional €1.5million ($1.8 million) for a total of €7.9 million in its Series B financing round, the company said yesterday.

The Ghent, Belgium-based firm plans to use the funds raised in the round to develop technologies for cardio-renal, pre-eclampsia, sepsis, and ovarian cancer diagnostics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.